Spruce Biosciences, Inc.
SPRBBiotechnology
$46.39−0.92%As of Oct 30vs prior close
- Market cap
- $133.3M
- P/E (TTM)
- –
- From 52W high
- −63.47%
- EPS (YE25)
- -$50.83
- Revenue (YE25)
- $0
- Dividend yield
- 0.00%
Nomior Score
20
Distressed LaggardBottom 7% of the scored universe
Growth—
Quality25
Value54
Momentum10
Resilience26
Growth
$0revenue, YE25
YE22 $0YE25 $0
Connections
Revenue to profitQ4 YE24
The operating loss was 3454% of revenue, wider by 3067 pts on a year.
Who owns it
2funds